Products Categories
CAS No.: | 61337-67-5 |
---|---|
Name: | Mirtazapine |
Article Data: | 40 |
Cas Database | |
Molecular Structure: | |
|
|
Formula: | C17H19N3 |
Molecular Weight: | 265.358 |
Synonyms: | Mirtabene;2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; |
EINECS: | 288-060-6 |
Density: | 1.22 g/cm3 |
Melting Point: | 114-116 °C |
Boiling Point: | 432.4 °C at 760 mmHg |
Flash Point: | 215.3 °C |
Solubility: | DMSO: 8 mg/mL |
Appearance: | white crystalline solid |
Hazard Symbols: | F,T |
Risk Codes: | 11-23/24/25-39/23/24/25 |
Safety: | 22-24/25 |
PSA: | 19.37000 |
LogP: | 2.48180 |
IUPAC Name: (±)-1,2,3,4,10,14B-Hexahydro-2-[11C]methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
Molecular Formula: C17H19N3
Molecular Weight: 265.35 g/mol
Canonical SMILES: N12[C@@H](c3c(cccc3)Cc3c1nccc3)C[N@@](C)CC2
InChI: InChI=1/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3
Product Categories: Intermediates & Fine Chemicals; Pharmaceuticals; Serotonin
Classification Code: Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-antagonists; Antidepressant; Antidepressive Agents; Antidepressive agents, tricyclic; Central Nervous System Agents; Histamine Agents; Histamine Antagonists; Histamine H1 antagonists; Neurotransmitter Agents; Psychotropic Drugs
Melting Point: 114-116 °C
solubility DMSO: 8 mg/mL, soluble
Index of Refraction: 1.667
Molar Refractivity: 80.68 cm3
Molar Volume: 216.5 cm3
Polarizability: 31.98×10-24 cm3
Surface Tension: 59.4 dyne/cm
Density: 1.22 g/cm3
Flash Point: 215.3 °C
Enthalpy of Vaporization: 68.82 kJ/mol
Boiling Point: 432.4 °C at 760 mmHg
Vapour Pressure of Mirtazapine (CAS NO.61337-67-5): 1.11E-07 mmHg at 25 °C
Mirtazapine was introduced by Organon International in the United States in 1990 for the treatment of depression. It quickly spread throughout most of the rest of the world as well and became a widely used antidepressant, particularly for those desiring to gain weight.
Mirtazapine (CAS NO.61337-67-5) is a tetracyclic antidepressant (TeCA) used primarily in the treatment of depression. It is also sometimes used as an anxiolytic, hypnotic, antiemetic, appetite stimulant, and antihistamine, among other indications. Along with its close analogues mianserin and setiptiline, mirtazapine is one of the few noradrenergic and specific serotonergic antidepressants (NaSSAs).
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 1071ug/kg/I (1.071mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Journal of Clinical Psychiatry. Vol. 59, Pg. 233, 1998. |
Human systemic effects. When heated to decomposition it emits toxic vapors of NOx.
Safety Statements: 22-24/25
S22:Do not breathe dust.
S24/25:Avoid contact with skin and eyes.
WGK Germany of Mirtazapine (CAS NO.61337-67-5): 3
Mirtazapine (CAS NO.61337-67-5), its Synonyms are 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine ; Mirtazapina ; Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl- ; Remeron ; Remeron SolTab . It is white crystalline solid.